2023-12-02 02:23:24
As of December 1st, 2023, a new corona variant in the USA is causing concern among doctors and researchers for its potential to cause chronic bronchitis. The HV.1 variant is becoming the dominant variant among Covid-19 infections in the United States, rising from 0.5 percent of new infections in July 2023 to 25.2 percent in November of the same year.
According to reports, HV.1 primarily affects the bronchi, leading to symptoms such as a stuffy nose, sore throat, runny nose, cough, exhaustion, headache, fever, chills, and muscle pain. In addition, the variant is believed to cause a type of chronic bronchitis, resulting in a prolonged cough that lasts beyond the typical recovery period from other symptoms.
Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University, has emphasized the importance of closely monitoring the variant due to its potential to cause chronic bronchitis. Despite its unique characteristic, there is currently no evidence to suggest that HV.1 is more contagious than other mutations.
While HV.1 has not been detected in Germany thus far, the country has seen a significant increase in the total number of infections since the beginning of October. As a result, the usual preventive measures, such as regular hand washing and maintaining a balanced, healthy diet, continue to be recommended to protect against corona infections.
The rise of the HV.1 variant serves as a reminder of the ongoing threat of Covid-19 and the need for continued vigilance in the face of new variants and potential health implications.]
#Corona #mutation #attack #bronchi